Bridgewater Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$319K Sell
4,082
-31
-0.8% -$2.32K 0.02% 354
2025
Q4
$315K Buy
4,113
+140
+4% +$11.1K 0.02% 343
2025
Q3
$302K Buy
3,973
+19
+0.5% +$1.5K 0.02% 345
2025
Q2
$307K Buy
3,954
+25
+0.6% +$1.93K 0.02% 331
2025
Q1
$300K Buy
+3,929
New +$327K 0.03% 322
2022
Q3
Sell
-4,400
Closed -$276K 183
2022
Q2
$276K Buy
4,400
+6
+0.1% +$397 0.06% 192
2022
Q1
$309K Sell
4,394
-511
-10% -$34.5K 0.08% 187
2021
Q4
$307K Buy
4,905
+1,121
+30% +$70.4K 0.07% 191
2021
Q3
$234K Buy
3,784
+42
+1% +$2.53K 0.06% 219
2021
Q2
$224K Sell
3,742
-260
-6% -$16.5K 0.07% 218
2021
Q1
$254K Buy
+4,002
New +$221K 0.13% 142

Other funds holding MET

Bridgewater Advisors's MET Position: Q1 2026 in Review

Bridgewater Advisors reduced its MetLife (MET) stake by 0.75% in Q1 2026, selling an estimated $2.32K and leaving 4,082 shares worth $319K. The position accounts for 0.02% of the portfolio, ranked #354.

Bridgewater Advisors first reported a position in MET in Q1 2021 and has held it in 11 quarters since. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Bridgewater Advisors held 4,082 shares of MetLife worth $319K as of Q1 2026.
  • Bridgewater Advisors sold 31 MetLife shares in Q1 2026, an estimated $2.32K.
  • MetLife made up 0.02% of Bridgewater Advisors's portfolio in Q1 2026, its #354 holding.
  • Bridgewater Advisors first reported a position in MetLife in Q1 2021 and has held it in 11 quarters since.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.